Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome

NCT01945892 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.

NCT NCT01945892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01945892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome
Lead sponsor
Ludwig-Maximilians - University of Munich
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
July 31, 2013
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, visual acuity